Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2019-08-13 Director's Dealing
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2019-08-13 English
FORM 4 SUBMISSION
Director's Dealing
2019-08-12 English
Interim / Quarterly Report 2019
Interim / Quarterly Report Q2 2019
2019-08-06 English
Earnings Release 2019
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02, which relates to the "Results of Operations and Financial Condition" and references a press release about financial results for the second quarter ended June 30, 2019. The document states that the press release is attached as Exhibit 99.1 and that the information is being furnished, not filed, indicating this is an announcement of financial results rather than the full financial report itself. The document length is 3707 characters, which is relatively short and consistent with an 8-K filing announcing earnings results. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Therefore, the correct classification is ER with high confidence.
2019-08-06 English
Regulatory Filings 2019
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events or other material information that occurs between periodic reports. The text includes an announcement about the FDA accepting a New Drug Application and a press release attached as an exhibit. There are no financial statements or detailed financial data presented, and the document is relatively short (3555 characters). It is not an annual or quarterly report, nor an earnings release. It is not a certification or a proxy statement. The content fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories.
2019-08-01 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 12, 2019, by Eton Pharmaceuticals, Inc. It reports an event under Item 8.01 Other Events, specifically the issuance of a press release about the FDA providing a Complete Response Letter regarding a product candidate. The document includes no financial statements or detailed financial data, only a brief event disclosure and an attached press release. The length is 3399 characters, which is relatively short and consistent with a current report rather than a full financial report. Form 8-K filings are current reports used to disclose material events and are classified under Regulatory Filings (RNS) as they do not fit into other specific categories like Annual Report or Earnings Release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-07-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.